| TUPEE21 | No data no more: a tool to end the exclusion of trans and gender-diverse people in HIV research | Poster exhibition | Innovations in data collection, monitoring and evaluation |
| TUPEE22 | The progress and utility of HIV case-based surveillance in Kenya for public health response, 2014-2022 | Poster exhibition | Innovations in data collection, monitoring and evaluation |
| TUPEE23 | A pilot study of Paediatric Dolutegravir (pDTG) automation using technology to improve adherence among children living with HIV in Akwa-Ibom State | Poster exhibition | Innovations in data collection, monitoring and evaluation |
| TUPEE24 | Favorable outcomes of Option B+ strategy despite COVID-19 restrictions: retrospective cohort study in Zambézia Province, Mozambique (2019-2021) | Poster exhibition | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| TUPEE25 | Using HIV platform to improve COVID-19 vaccination uptake through a combination intervention approaches in Eastern Province, Zambia | Poster exhibition | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| TUPEE26 | Exploring the impact of the COVID pandemic on sexual health services in community health centers across the US | Poster exhibition | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| TUPEE27 | Lessons learnt from an HIV continuity-of-treatment surge initiative to alleviate the effect Of COVID-19 pandemic on HIV care in National Capital District, Papua New Guinea | Poster exhibition | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |